Sort
10,766 grants matching “checkpoint inhibitor”
Targeting head and neck cancer cells and the adverse tumor microenvironment with a novel small-molecule STAT3 inhibitor
$666,718David John Tweardy · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
$666,466Diane M Simeone · New York University School Of Medicine · R01 · FY2022 · CA
[18F]F-AraG as an imaging biomarker for early diagnosis and monitoring of cardiotoxicity related to doxorubicin and immune check point inhibitor therapy
$666,104Youngho Seo · University Of California, San Francisco · R01 · FY2024 · HL
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$665,918Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA
An urinary drug disposing approach for treatment of bladder Cancer
$665,916Benedict Shek Hang Law · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Using artificial intelligence to discover spatial, genomic, and pathologic biomarkers to guide and augment immune checkpoint inhibitor therapy for gastric cancer
$665,617Sam C. Wang · Ut Southwestern Medical Center · R01 · FY2025 · CA
A prospective evaluation of the gut microbiome as a mediator of lymphoma treatment outcome and systemic immunity
$665,532Catherine Sibyl Diefenbach · New York University School Of Medicine · R01 · FY2024 · CA
Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer
$665,456Meghan E. Sise · Massachusetts General Hospital · R01 · FY2025 · DK
Determinants of toxicity and response to immune checkpoint blockade through integrative profiling of T cell clonal dynamics and plasma cell- free DNA
$665,413Aadel Chaudhuri · Mayo Clinic Rochester · R01 · FY2025 · CA
Integrated blood and radiomic subtyping to guide immunotherapy treatment selection and early response assessment in metastatic non-small cell lung cancer
$665,352Natalie Vokes · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Developing a novel combination immunotherapy for triple-negative breast cancer
$664,874Naoto T Ueno · University Of Hawaii At Manoa · R01 · FY2023 · CA
Elucidating the role of transcriptomics in driving ethnicity and ancestry-related disparities in colorectal cancer
$664,795Jane C. Figueiredo · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Implications of Changes in Islet Exosomal Cargo in Type 1 Diabetes
$664,681Emily K Sims · Indiana University Indianapolis · R01 · FY2024 · DK
Biological and social determinants of psychosocial sequelae in advanced head and neck cancer survivors receiving immunotherapy
$664,304Canhua Xiao · Emory University · R01 · FY2024 · CA
Regulation of Mitotic Kinetochores by the Ran GTPase
$664,047Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Image-guided cancer therapy using heat activatable CAR T cells
$664,037Stanislav Y Emelianov · Georgia Institute Of Technology · R01 · FY2023 · EB
Optimizing immunoradiotherapy for HNSCC
$663,994Joseph A Califano · University Of California, San Diego · R01 · FY2025 · CA
Pathway-guided treatment of immune checkpoint inhibitor therapy-induced colon toxicity
$663,989Jennifer D Wu · Northwestern University At Chicago · R01 · FY2025 · CA
Pathway-guided treatment of immune checkpoint inhibitor therapy-induced colon toxicity
$663,989Jennifer D Wu · Northwestern University At Chicago · R01 · FY2023 · CA
Nutrient Regulation of Cancer Cell Growth
$663,928Heather Christofk · University Of California Los Angeles · R01 · FY2023 · CA
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies
$663,909James R. Heath · Institute For Systems Biology · U54 · FY2018 · CA
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$663,862Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2022 · CA
Regulation of Mitotic Kinetochores by the Ran GTPase
$663,662Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
Data Processing, Analysis and Modeling Unit
$663,501Jeremy Goecks · Oregon Health & Science University · U2C · FY2021 · CA
ER stress-driven IRE1a-XBP1 signaling in lung cancer
$663,481Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA